top of page

Frontiers Topic Open for Submissions - Enzymes in Brain Trauma and Disease

Frontiers is the 3rd most-cited research publisher and reports groundbreaking discoveries by the world's top experts. Frontiers, Experimental Therapeutics is now accepting submissions that highlight the roles of enzymes in neurological injury or disease. Authors are also encouraged to submit relevant work describing enzymes associated with infectious agents, e.g. SARS-CoV-2, as applicable to neurological symptoms and / or damage.

Visit Frontiers to learn more

To learn how we can assist with your needs within science and medicine, visit Aries Biotech at

11 views0 comments

Recent Posts

See All

Honored to serve as a guest speaker for the Neuroscience Roadmap Scholars Program within the Department of Neurobiology, University of Alabama at Birmingham. A link to the UAB Neuroscience Program ma

Aries Biotech is pleased to announce new hours of operation! Effective 01 October 2022, hours of operation will be Monday-Thursday, 8am to 6pm (PST) by appointment. This change will help to accommod

bottom of page